Key Takeaways
- • Enpam, Italy's €30bn pension fund for doctors, commits €220m across venture capital and listed small-cap equities to optimize domestic tax incentives and support Italy's real economy.
- • €120m allocated to Fondo Nazionale Strategico Indiretto (FNSI), a state-backed fund of funds managed by CDP investing in companies listed on Euronext Milan and Euronext Growth Milan; FNSI completed first close at approximately €500m across six approved asset managers (Generali, Eurizon, Amundi, Miria, Arca, Anima).
- • €100m committed across 10 venture capital funds focused on healthcare and biopharma sectors, with eight small-cap equity managers receiving individual commitments ranging from €7.5m to €20m.
- • Tax incentive structure drives allocation strategy: Italian pension funds must invest minimum 5% of qualified investments in VC in 2026, rising to 10% in 2027, with Enpam targeting approximately €105m to meet the current-year threshold per its 2025 financial statements.
- • Capital deployment addresses regulatory compliance while positioning Enpam to capture tax exemptions available exclusively to first-pillar professional pension funds (casse di previdenza) and second-pillar industry-wide pension funds (fondi negoziali).
Summary
Enpam, the €30bn Italian pension fund for medical professionals, has approved a €220m investment program split between venture capital and listed small and mid-cap equities, leveraging domestic tax incentives while strengthening its allocation to the Italian real economy. The commitment reflects both strategic portfolio diversification and compliance with recently implemented tax regulatory requirements governing Italian pension fund allocations.
The investment strategy comprises two primary components. First, Enpam committed €120m to the Fondo Nazionale Strategico Indiretto (FNSI), a state-backed strategic investment vehicle managed by Cassa Depositi e Prestiti (CDP). FNSI operates as a fund of funds structure, deploying capital into companies listed on Euronext Milan and Euronext Growth Milan through fund managers approved by Italian securities regulator CONSOB and CDP. Six asset managers—Generali, Eurizon, Amundi, Miria, Arca, and Anima—have received CONSOB approval. According to Il Sole 24 Ore, FNSI completed its first close at approximately €500m in committed capital from institutional investors. In the small-cap equity strategy, Enpam selected eight managers with individual commitments ranging from €7.5m to €20m to target listed Italian SMEs.
The second component allocates €100m across 10 venture capital funds. Enpam identified venture capital investment as a priority mechanism to support innovation in healthcare and biopharma sectors while supporting the broader Italian economy. This allocation is directly motivated by tax exemption thresholds established by Italy's Revenue Agency (Agenzia delle Entrate), which require first-pillar pension funds for professionals and second-pillar industry-wide pension funds to invest a minimum of 5% of qualified investments in venture capital during 2026, rising to 10% in 2027. According to Enpam's 2025 financial statements, the pension fund targeted approximately €105m in VC commitments to meet the current-year compliance threshold.
The €220m commitment underscores how regulatory tax policy shapes institutional capital allocation in Italy's pension fund ecosystem while reflecting Enpam's strategic shift toward granular exposure to domestic innovation and growth-stage companies. The timing aligns with both regulatory deadlines and the maturation of state-backed infrastructure for domestic small-cap and venture capital investment, with FNSI providing an institutional vehicle to facilitate pension fund participation in fragmented Italian equity markets.
The investment strategy comprises two primary components. First, Enpam committed €120m to the Fondo Nazionale Strategico Indiretto (FNSI), a state-backed strategic investment vehicle managed by Cassa Depositi e Prestiti (CDP). FNSI operates as a fund of funds structure, deploying capital into companies listed on Euronext Milan and Euronext Growth Milan through fund managers approved by Italian securities regulator CONSOB and CDP. Six asset managers—Generali, Eurizon, Amundi, Miria, Arca, and Anima—have received CONSOB approval. According to Il Sole 24 Ore, FNSI completed its first close at approximately €500m in committed capital from institutional investors. In the small-cap equity strategy, Enpam selected eight managers with individual commitments ranging from €7.5m to €20m to target listed Italian SMEs.
The second component allocates €100m across 10 venture capital funds. Enpam identified venture capital investment as a priority mechanism to support innovation in healthcare and biopharma sectors while supporting the broader Italian economy. This allocation is directly motivated by tax exemption thresholds established by Italy's Revenue Agency (Agenzia delle Entrate), which require first-pillar pension funds for professionals and second-pillar industry-wide pension funds to invest a minimum of 5% of qualified investments in venture capital during 2026, rising to 10% in 2027. According to Enpam's 2025 financial statements, the pension fund targeted approximately €105m in VC commitments to meet the current-year compliance threshold.
The €220m commitment underscores how regulatory tax policy shapes institutional capital allocation in Italy's pension fund ecosystem while reflecting Enpam's strategic shift toward granular exposure to domestic innovation and growth-stage companies. The timing aligns with both regulatory deadlines and the maturation of state-backed infrastructure for domestic small-cap and venture capital investment, with FNSI providing an institutional vehicle to facilitate pension fund participation in fragmented Italian equity markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.